首页
外语
计算机
考研
公务员
职业资格
财经
工程
司法
医学
专升本
自考
实用职业技能
登录
外语
The European Commission said on Thursday it would toughen the regulation of medical devices as a result of concerns raised by br
The European Commission said on Thursday it would toughen the regulation of medical devices as a result of concerns raised by br
admin
2011-02-03
43
问题
The European Commission said on Thursday it would toughen the regulation of medical devices as a result of concerns raised by breast implants produced by the defunct French company PIP, even as a scientific expert review it ordered concluded there was currently "insufficient evidence" that women using its products faced greater health risks than others.
John Dalli, health and consumer policy commissioner, pledged to examine surveillance and operation of the "notified bodies" that scrutinise medical devices across the EU in a current review of legislation, stressing: "The capacity to detect and minimise the risk of fraud must be increased."
His comments followed an official report released on Wednesday in France that called for national and EU-wide co-operation including random inspections and sampling of medical devices to prevent a repeat of the fraudulent use of substandard non-medical-grade silicone by PIP in implants sold to up to 400,000 women around the world.
Xavier Bertrand, France’s minister of health, called for enhanced action in France and across Europe in the wake of the study, which highlighted that Afssaps, the French medical regulator, did not inspect PIP from 2001 until a tip-off led officials to inspect and close down the company in 2010. Jean-Claude Mas, its founder, is under police investigation for manslaughter.
Mr. Bertrand has pledged to hire more health inspectors and undertake random checks on medical device companies following growing concerns over its regulatory system highlighted by the widespread use of PIP’s substandard breast implants.
A French decision at the end of last year to offer all women free removal of PIP implants triggered similar proposals in the UK, Germany and the Czech Republic and has helped spark a fresh debate over tougher EU regulation of medical devices, which are subject to far less scrutiny than pharmaceuticals.
However, a review released on Thursday by the EU’s own Scientific Committee on Emerging and Newly Identified Health Risks concluded: "Breast implants can fail, regardless of manufacturer, and the probability of failure increases with time since implantation. In most cases, breast implant failure appears to be without identifiable health consequences for the patient with the exception of possible local complications."
It stressed that limited data meant that while there was no link between breast implants and cancer, there was a need for further work to understand the specific risks from the PIP products.
Mr. Bertrand has endorsed calls for a parliamentary inquiry in France as well as a report from the country’s social affairs inspectorate, mirroring similar moves that led to tough new requirements for the pharmaceutical industry introduced last year in the wake of concerns about Servier’s drug Mediator.
Medical device manufacturers have called for reforms to ensure that the national "notified bodies" which audit the quality of their products across Europe are of a consistently high standard, while cautioning that tough new regulatory requirements could harm the EU’s competitive advantage.
The French study showed that Afssaps had received multiple warnings over the relatively high failure rate of PIP implants compared with those made by other companies, even though the overall proportion remained modest.
From Financial Times, February 2, 2012
Which of the following countries have not all proposed to offer women free removal of PIP implants?
选项
A、France, Germany, UK
B、Germany, UK, Czech
C、US, Germany, Czech
D、Germany, France, Czech
答案
C
解析
本题为细节题。根据第六段“A French decision at the end of last year to offer all women free removal of PIP implants triggered similar proposals in the UK,Germany and the Czech Republic”可知提出这项建议的国家为France,UK,Germany and Czech。全文都在讲EU,没有提到US。故C错误。
转载请注明原文地址:https://kaotiyun.com/show/SM1K777K
0
专业英语四级
相关试题推荐
Peoplealwayssayhellotoeachotherwhen______.
Thecommitteemembersresented______themofthemeeting.
Awellcoherentdiscourse______goodchoiceofcohesivedevicesandsemanticselectionamongotherthings.
Thegreatestrecentsocialchangeshavebeen【C1】______thelivesofwomen.Duringthe20thcenturytherehasbeenaremarkable
Thegreatestrecentsocialchangeshavebeen【C1】______thelivesofwomen.Duringthe20thcenturytherehasbeenaremarkable
WriteonANSWERSHEETONEanoteofabout50~60wordsbasedonthefollowingsituation:Youfailedtomeetyourformerclassm
Whyisthemantalkingtothewoman?
Adamshadn’ta______whatthespeakerwastalkingaboutmostofthetimebecausetheclasswasinchaos.
By1950.theresultsofattemptstorelatebrainprocessestomentalexperienceappearedratherdiscouraging.Suchvariationsin
SEATTLE(Reuters)-Initsseconddtenteinasmanymonths,MicrosoftCorp.onFridaysaidithaspartneredwithlongtimerival
随机试题
下列哪项属于肠外营养本身引起的并发症
影响免疫浊度测定的因素,不包括A.抗原与抗体的比例B.温度C.盐浓度D.抗体的质量E.增强剂
A.咨询B.个别访谈C.劝服D.指导E.反馈说服教育对象改变不正确的健康态度、信念及行为习惯的人际传播形式称为
视网膜中央动脉阻塞的患眼瞳孔
患者吴某,男性,45岁。来诊时症见不寐多梦,甚则彻夜不寐,面红目赤,语声高亢,情绪激动,口干苦而渴,不思饮食,小便短赤,大便秘结,舌质红,苔黄,脉弦而数。其治法是
既能止血生肌,又能消散痈肿的药物是
特别适合费时较长的手术,术后镇痛时间也较长的是()
天美公司诉地盛公司金融借款合同一案,在诉讼过程中.天美公司将本案所涉债权转让给了案外人人合公司。关于本案审理,以下选项正确的是:()
计算机病毒是一种()。
甲、乙、丙、丁按份共有一栋房屋,份额相同。为提高该房屋使用价值,甲向乙、丙、丁提议拆旧翻新,在共有人之间未就该事项做出明确约定的情况下,下列表述中,符合《物权法》规定的是()。
最新回复
(
0
)